cáncer de ovario en el instituto nacional de oncología y radiobiología de cuba: 2001 a 2005 ovarian cancer at the national institute of oncology and radiobiology of cuba: 2001-2005
Clicks: 185
ID: 132125
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
185 views
28 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #24 of 54 articles by views in chemistry and biodiversity
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
INTRODUCCIÓN. El cáncer de ovario ocupa el tercer lugar entre los cánceres ginecológicos y a él se debe el 5 % de todas las muertes por cáncer. El objetivo del presente estudio fue conocer la incidencia hospitalaria, la respuesta al tratamiento y la supervivencia global del cáncer de ovario en nuestra institución, durante un quinquenio. MÉTODOS. Se realizó un estudio retrospectivo, descriptivo, lineal con 192 mujeres con tumores de ovario. Se excluyeron aquellas con tumores benignos o tumores no extirpables, y las que no recibieron tratamiento oncoespecífico o lo recibieron y fueron seguidas en otros hospitales. RESULTADOS. Los grupos etarios más afectados correspondieron al quinto y sexto decenios de la vida (40,4 %) y la media de edad fue de 48 años. La etapa clínica más frecuente fue la III (261 %) de las mujeres, y el 44,2 % estaba en estadio IIIc. El tipo histológico más frecuente fue el adenocarcinoma papilar seroso (H" 70 %), entre los cánceres epiteliales (49; 94,23 %). La supervivencia global media de las pacientes que recibieron tratamiento quirúrgico fue de 31 meses. Al finalizar el estudio la tasa de supervivencia era menor del 40 %. En las pacientes que no respondieron a la quimioterapia la supervivencia a los 36 meses fue nula. CONCLUSIONES. El comportamiento del cáncer ovárico en el Instituto Nacional de Oncología y Radiobiología de Cuba no difiere mucho de lo reportado en la literatura médica mundial.
INTRODUCTION. Ovarian cancer occupies the third place among the gynecological cancers, and it causes 5 % of all the deaths from cancer. The objective of this study is to know the hospital incidence, the response to the treatment and the global survival of ovarian cancer in our institution during a five-year term. METHODS. A descriptive, retrospective and lineal study was carried out among 192 females with ovarian tumors. Those with benign or non resectable tumors were excluded, as well as the patients that did not receive oncospecific treatment or that received it, but were followed-up in another hospital. RESULTS. The most affected age groups were in the fifth and sixth decades of life (40.4 %). Mean age was 48 years old. The most common clinical stage was the stage III (261 % of the females). 44.2 % were at stage IIIc. The most frequent histological type was the serous papillary adenocarcinoma (H" 70 %) among the epithelial cancers (49; 94.23 %). The global mean survival of the patients that received surgical treatment was 31 months. At the end of the study, the survival rate was under 40 %. Survival after the 36 months was null among the patients that did not respond to chemotherapy. CONCLUSIONS. The behavior of ovarian cancer at the National Institute of Oncology and Radiobiology does not differ to much from what is reported by the world medical literature
INTRODUCTION. Ovarian cancer occupies the third place among the gynecological cancers, and it causes 5 % of all the deaths from cancer. The objective of this study is to know the hospital incidence, the response to the treatment and the global survival of ovarian cancer in our institution during a five-year term. METHODS. A descriptive, retrospective and lineal study was carried out among 192 females with ovarian tumors. Those with benign or non resectable tumors were excluded, as well as the patients that did not receive oncospecific treatment or that received it, but were followed-up in another hospital. RESULTS. The most affected age groups were in the fifth and sixth decades of life (40.4 %). Mean age was 48 years old. The most common clinical stage was the stage III (261 % of the females). 44.2 % were at stage IIIc. The most frequent histological type was the serous papillary adenocarcinoma (H" 70 %) among the epithelial cancers (49; 94.23 %). The global mean survival of the patients that received surgical treatment was 31 months. At the end of the study, the survival rate was under 40 %. Survival after the 36 months was null among the patients that did not respond to chemotherapy. CONCLUSIONS. The behavior of ovarian cancer at the National Institute of Oncology and Radiobiology does not differ to much from what is reported by the world medical literature
| Reference Key |
reigosa2009revistacncer
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Juan Edmundo Rodríguez Reigosa;Lorena Patricia Guerrero García;Roberto Pablo Esperón Noa;Alejandro Linchenat Lambert;Juan Mario Silveira Pablos;Israel Díaz Ortega;Francisco Orlando Aguilar Vela de Oro;Omar de Jesús Bosque Diego;Jorge Felipe Montero León |
| Journal | chemistry and biodiversity |
| Year | 2009 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.